Sandra[a]
A Phase I trial of escalating oral doses of SCH66336 in pediatric patients with refractory or recurrent brain tumors.
Age Group: Pediatric Only
Min Karnofsky Score: 60: Requires occasional assistance but is able to care for most of own needs
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Tumor Types: Brainstem Glioma
Recurrent Malignant Pediatric Brain Tumors
Contact: Henry Friedman MD
Duke Comprehensive Cancer Center
Rm 047 Baker House, Hospital South
Trent Drive
Durham, NC 27710- USA
Phone: (919)684-5301
Fax: (919)684-6674